PharmaTher Holdings Ltd.
PHRM
CNSX
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.85% | 6.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.73% | -38.31% | |||
| Operating Income | 11.73% | 38.31% | |||
| Income Before Tax | 99.04% | 44.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 99.04% | 44.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 99.04% | 44.41% | |||
| EBIT | 11.73% | 38.31% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 100.00% | 42.86% | |||
| Normalized Basic EPS | 100.00% | 35.29% | |||
| EPS Diluted | 100.00% | 42.86% | |||
| Normalized Diluted EPS | 100.00% | 35.29% | |||
| Average Basic Shares Outstanding | 0.00% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||